"There is a huge emergence of local Africans that chose to come to South Africa for elective surgery, whether it be breastreduction, tummy tucks, lipo, " she says.
Professor David Sharpe, a consultant plastic surgeon based at Bradford Royal Infirmary, said he had failed to persuade medical insurance companies to pay for breastreduction surgery even in cases where it was obvious that the patient required the operation on medical grounds.
Results from a 9, 366-patient trial showed that those on Arimidex had a 17% reduction in the risk of breast cancer recurrence compared with patients on Nolvadex.